Actively Recruiting
AI-Based Cognitive Digital Therapeutics System Using Generative Content for Managing Dementia in Adults 50 and Older
Led by Taipei Medical University WanFang Hospital · Updated on 2025-02-19
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating an AI-driven cognitive digital therapeutics system designed to support people with mild neurocognitive disorder or dementia, aged 50 years and older. The study aims to assess the effects of this digital therapy on daily living activities and cognitive function compared to usual care. The trial is randomized and double-blind, sponsored by Taipei Medical University WanFang Hospital. Participants in the intervention group will receive digital therapeutics sessions three times per week for eight weeks. During each session, patients perform tasks using objects following instructions displayed by a device, while a camera records their performance for analysis. The control group will receive standard care without these digital sessions. Evaluations occur at the start, at week 8, and at week 16 to monitor progress. Throughout the study, participants will be assessed with several cognitive and functional tests including the Instrumental Activities of Daily Living IADL, Montreal Cognitive Assessment MoCA, Mini-Mental State Examination MMSE, Clinical Dementia Rating CDR, and Executive Function Performance Test EFPT. These measurements will be taken at baseline, week 8, and week 16. The study will also monitor safety and adherence, with total participation lasting at least 16 weeks.
CONDITIONS
Brief Title
AI-Driven Cognitive Digital Therapeutics for Dementia Management
Research Team
T
Tian-Shin Yeh, MD, MMSc, PhD
J
Jowy Tani, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
